Efficacy and Safety of Semaglutide for the Management of Obese Patients With Type 2 Diabetes and Chronic Heart Failure in Real-World Clinical Practice.
Pérez-Belmonte LM, Sanz-Cánovas J, García de Lucas MD, Ricci M, Avilés-Bueno B, Cobos-Palacios L, Pérez-Velasco MA, López-Sampalo A, Bernal-López MR, Jansen-Chaparro S, Miramontes-González JP, Gómez-Huelgas R.
Pérez-Belmonte LM, et al. Among authors: garcia de lucas md.
Front Endocrinol (Lausanne). 2022 Jun 24;13:851035. doi: 10.3389/fendo.2022.851035. eCollection 2022.
Front Endocrinol (Lausanne). 2022.
PMID: 35813629
Free PMC article.